Aurora Cannabis (ACB) Change in Receivables (2017 - 2018)

Aurora Cannabis (ACB) posted quarterly Change in Receivables of -$7.9 million for Q4 2018, down 5571.69% year-on-year from $145232.6 in Q4 2017, and down 576.96% on a QoQ basis from $1.7 million in Q3 2018.

Aurora Cannabis (ACB) Change in Receivables (2017 - 2018) Analysis & Trends

Aurora Cannabis (ACB) has reported Change in Receivables for 2 consecutive years, with -$7.9 million the latest figure, recorded in Q4 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -78.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 106.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -621.82 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -38.20 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 126.30 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 81.40 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Aurora Cannabis 1.11 Bn 1.03 Bn 21.72 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2018 -7.95 Mn
Dec 31, 2018 -7.95 Mn
Sep 30, 2018 1.67 Mn
Sep 30, 2018 1.67 Mn
Dec 31, 2017 -140,111.32
Dec 31, 2017 -140,111.32
Sep 30, 2017 178,619.02
Sep 30, 2017 178,619.02